Chemical and Systems Biology
Showing 41-60 of 100 Results
-
Daniel Jarosz
Senior Associate Dean, Basic Science, Professor of Chemical and Systems Biology and of Developmental Biology
Current Research and Scholarly InterestsMy laboratory studies conformational switches in evolution, disease, and development. We focus on how molecular chaperones, proteins that help other biomolecules to fold, affect the phenotypic output of genetic variation. To do so we combine classical biochemistry and genetics with systems-level approaches. Ultimately we seek to understand how homeostatic mechanisms influence the acquisition of biological novelty and identify means of manipulating them for therapeutic and biosynthetic benefit.
-
Patrick Jurney
Affiliate, Chemical and Systems Biology Operations
Visiting Scholar, Chemical and Systems Biology OperationsBioPatrick Jurney is the Kordestani Endowed Chair and an Associate Professor of Biomedical Engineering at San Jose State University. A Fellow of the American Heart Association (FAHA), his research focuses on the intersection of fluid dynamics and cellular mechanics, with a particular emphasis on cardiovascular health and disease..
Dr. Jurney completed his Ph.D. in Thermal Fluid Systems at the University of Texas at Austin, where he designed and built microphysiological systems to investigate the role of nanoparticle properties in targeted drug delivery. Following his doctoral studies, he was a T-32 Fellow in Translational Engineering at Oregon Health & Science University (OHSU). During his fellowship, he worked with cardiovascular biomaterials and characterized how biomaterial properties influence endothelialization and thrombogenesis.
Currently, his research laboratory at SJSU investigates the role of fluid shear stress mechanotransduction on endothelial metabolic structure and function. Dr. Jurney is a pioneer in using holotomographic microscopy to study sub-cellular organelles in cardiovascular disease. He is also collaborating in the laboratory of Dr. Daria Mochly-Rosen to characterize the role of mitochondrial structure and dynamics in metabolic function in response to ischemia/reperfusion and other models of cardiovascular health and disease.
Website: https://www.jurneylab.org/
Email: patrick.jurney@sjsu.edu or pjurney@stanford.edu -
Michael Lin
Professor of Neurobiology, of Bioengineering and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur lab applies biochemical and engineering principles to the development of protein-based tools for investigating biology in living animals. Topics of investigation include fluorescent protein-based voltage indicators, synthetic light-controllable proteins, bioluminescent reporters, and applications to studying animal models of disease.
-
Nicole M. Martinez
Assistant Professor of Chemical and Systems Biology and of Developmental Biology
Current Research and Scholarly InterestsThe Martinez lab studies RNA regulatory mechanisms that control gene expression. We focus on mRNA processing, RNA modifications and their roles in development and disease.
-
Mark Mercola
Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology
BioDr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative high throughput assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.
Prof. Mercola received an NIH MERIT award for his work on heart formation. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the National Institutes of Health (NIH), California Institute for Regenerative Medicine, Phospholamban Foundation and Fondation Leducq.
